Harbin Medisan Pharmaceutical Co., Ltd. (SHE:002900)
China flag China · Delayed Price · Currency is CNY
12.02
-0.16 (-1.31%)
Mar 11, 2026, 10:25 AM CST

Harbin Medisan Pharmaceutical Company Description

Harbin Medisan Pharmaceutical Co., Ltd. engages in the research, development, production, and sale chemical pharmaceutical preparations in China.

The company offers various drugs for nervous system, cardiovascular system, systemic anti-infective, muscle and skeletal system, nutritional infusion, and body fluid balance infusion; and other products, including oxaliplatin for injection, calcium folinate for injection, hydroxylcamptothecine injection, tropisetron hydrochloride for injection, tropisetron hydrochloride and glucose injection, gabexate mesylate for injection, bismuth potassium citrate granules, pantoprazole sodium for injection, ambroxol hydrochloride and glucose injection, asarone for injection, paracetamol and tramadol hydrochloride tablets, rifamycin sodium for injection, lornoxicam for injection, vecuronium bromide for injection, and vitamin c for injection.

It also provides medical devices and cosmetics. Harbin Medisan Pharmaceutical Co., Ltd. was founded in 1996 and is headquartered in Harbin, China.

Harbin Medisan Pharmaceutical Co., Ltd.
Country China
Founded 1996
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 2,522
CEO Jian Fei Qin

Contact Details

Address:
The middle part of Beijing Road
Harbin, 150025
China
Phone 86 451 8560 8888
Website medisan.com.cn

Stock Details

Ticker Symbol 002900
Exchange Shenzhen Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE1000032V9
SIC Code 2834

Key Executives

Name Position
Jian Fei Qin Chairman and President
Zhicheng Zhao Financial Director
Yan Fei Liang Vice President, Board Secretary and Director
Xia Li Accounting Supervisor